Opinion
Video
Author(s):
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Experts Urge a New Standard for Short-Term Corticosteroid Use in Atopic Dermatitis
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Cigna Expands Coverage for Home Phototherapy
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Upadacitinib Sustains AD Control for 140 Weeks
A New Perspective on Seborrheic Dermatitis Management
Unlocking Skin's Potential from the Inside Out with Glutathione
The Aesthetic Edge: September 2025
Biofrontera Completes Enrollment and Active Treatment Phase in Phase 3 Ameluz PDT Trial for AK on the Body